Author

Chun Xu

The University of SydneyPrimary ORCID profile (0000-0001-5149-8257 · 5 papers)Unclaimed ORCID profile · follow to get notified of new preprints

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Same name, identified by ORCID

Chun XuiD5 papers · Chinese Academy of Sciences

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Assay:CRISPR screen· 1 Research Focus:drug response / drug discovery· 1 Organism:human· 1 Approach:machine learning (classical)· 1

Frequent Co-Authors

Derek Tran· 1 shared Graham J. ManniD· 1 shared Justin J. -L. WongiD· 1 shared Lenka MunoziD· 1 shared Ran XuiD· 1 shared Rebecca San GiliD· 1 shared Xin Tracy LiuiD· 1 shared Yanfei Qi· 1 shared

Activity by Year

2025-2025 · peak 1/yr

Co-Author Collaboration Network

9 top collaborators · 36 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Derek Tran

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

A blueprint for mutation-defined hallmark vulnerabilities across human cancers

Ran Xu, Rebecca San Gil, Xin Tracy Liu, Yanfei Qi, Derek Tran, Chun Xu, Justin J. -L. Wong, Lenka Munoz, Graham J. Mann, Yuchen Feng

This paper maps mutation-defined cancer vulnerabilities across 22 cohorts, identifying OXPHOS addiction in CDKN2A-loss LUSC and highlighting drug repurposing opportunities using a machine learning framework.

bioRxiv · Oct 24, 2025 · PreprintCancer Biology